12 articles5,051 citations
Primary Metastatic Osteosarcoma: Presentation and Outcome of Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols.Citation only
Kager, Bielack·J Clin Oncol·2003·967 citations
Soft Tissue and Visceral Sarcomas: Esmo–euracan–genturis Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up
Gronchi, Stacchiotti·Annals of Oncology·2021·901 citations
Survival and Prognosis with Osteosarcoma: Outcomes in More Than 2000 Patients in the EURAMOS-1 (european and American Osteosarcoma Study) Cohort.Citation only
Smeland, Marina·Eur J Cancer·2019·750 citations
Adjuvant Chemotherapy with Doxorubicin, Ifosfamide, and Lenograstim for Resected Soft-Tissue Sarcoma (EORTC 62931): A Multicentre Randomised Controlled Trial.Citation only
Woll, Hohenberger·Lancet Oncol·2012·597 citations
Comparison of MAPIE versus MAP in Patients with a Poor Response to Preoperative Chemotherapy for Newly Diagnosed High-Grade Osteosarcoma (EURAMOS-1): An Open-Label, International, Randomised Controlled Trial.
Marina, Whelan·The Lancet. Oncology·2016·531 citations
Bone Sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for Diagnosis, Treatment and Follow-Up.Citation only
Strauss, Stacchiotti·Ann Oncol·2021·492 citations
Nirogacestat, a Γ-Secretase Inhibitor for Desmoid Tumors.Citation only
Gounder, Kasper·N Engl J Med·2023·274 citations
Denosumab in Patients with Giant-Cell Tumour of Bone: A Multicentre, Open-Label, Phase 2 Study.Citation only
Chawla, Palmerini·Lancet Oncol·2019·257 citations
The Influence of Tumor- and Treatment-Related Factors on the Development of Local Recurrence in Osteosarcoma after Adequate Surgery. An Analysis of 1355 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols.Citation only
Andreou, Tunn·Ann Oncol·2011·158 citations
Vimseltinib versus Placebo for Tenosynovial Giant Cell Tumour (MOTION): A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial.Citation only
Gelderblom, Tap·Lancet·2024·80 citations
Malignancy in Giant Cell Tumor of Bone: Analysis of an Open-Label Phase 2 Study of Denosumab.Citation only
Palmerini, Picci·BMC Cancer·2021·39 citations
Undifferentiated Pleomorphic Sarcoma of Bone (UPSB) Treated in the German-Speaking Countries. A Report of 132 Unselected Patients from the Cooperative Osteosarcoma Study Group (COSS).Citation only
Bielack, Hecker-Nolting·J Cancer Res Clin Oncol·2026·5 citations